40 related articles for article (PubMed ID: 22855787)
1. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.
Cai Z; Zhang C; Chang KS; Jiang J; Ahn BC; Wakita T; Liang TJ; Luo G
J Virol; 2005 Nov; 79(22):13963-73. PubMed ID: 16254332
[TBL] [Abstract][Full Text] [Related]
2. Replication of a hepatitis C virus replicon clone in mouse cells.
Uprichard SL; Chung J; Chisari FV; Wakita T
Virol J; 2006 Oct; 3():89. PubMed ID: 17069661
[TBL] [Abstract][Full Text] [Related]
3. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.
Yi M; Villanueva RA; Thomas DL; Wakita T; Lemon SM
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2310-5. PubMed ID: 16461899
[TBL] [Abstract][Full Text] [Related]
4. Molecularly generated rat hepatitis E virus strains from human and rat show efficient replication in a human hepatoma cell line.
Panajotov J; Falkenhagen A; Gadicherla AK; Johne R
Virus Res; 2024 Jun; 344():199364. PubMed ID: 38522562
[TBL] [Abstract][Full Text] [Related]
5. In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis.
Saeed M; Shiina M; Date T; Akazawa D; Watanabe N; Murayama A; Suzuki T; Watanabe H; Hiraga N; Imamura M; Chayama K; Choi Y; Krawczynski K; Liang TJ; Wakita T; Kato T
Hepatology; 2011 Aug; 54(2):425-33. PubMed ID: 21538444
[TBL] [Abstract][Full Text] [Related]
6. Tree shrew bone marrow-derived mesenchymal stem cells express CD81, OCLN, and miR-122, facilitating the entire hepatitis C virus life cycle.
Lu C; Feng Y; Sun X; Li N; Kuang D; Wang W; Tong P; Han Y; Xia X; Dai J
J Med Virol; 2020 Dec; 92(12):3465-3474. PubMed ID: 32056224
[TBL] [Abstract][Full Text] [Related]
7. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
Wakita T; Pietschmann T; Kato T; Date T; Miyamoto M; Zhao Z; Murthy K; Habermann A; Kräusslich HG; Mizokami M; Bartenschlager R; Liang TJ
Nat Med; 2005 Jul; 11(7):791-6. PubMed ID: 15951748
[TBL] [Abstract][Full Text] [Related]
8. Transmission of human hepatitis C virus from patients in secondary cells for long term culture.
Revie D; Braich RS; Bayles D; Chelyapov N; Khan R; Geer C; Reisman R; Kelley AS; Prichard JG; Salahuddin SZ
Virol J; 2005 Apr; 2():37. PubMed ID: 15840164
[TBL] [Abstract][Full Text] [Related]
9. Robust hepatitis C virus infection in vitro.
Zhong J; Gastaminza P; Cheng G; Kapadia S; Kato T; Burton DR; Wieland SF; Uprichard SL; Wakita T; Chisari FV
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9294-9. PubMed ID: 15939869
[TBL] [Abstract][Full Text] [Related]
10. Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4
Skardasi G; Chen AY; Michalak TI
J Virol; 2018 Feb; 92(3):. PubMed ID: 29167333
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism.
Sarhan MA; Abdel-Hakeem MS; Mason AL; Tyrrell DL; Houghton M
Sci Rep; 2017 May; 7(1):2495. PubMed ID: 28566716
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytes as liver damage mirror of HCV related adipogenesis deregulation.
Minutolo A; Conti B; Grelli S; Viscomi C; Labbadia G; Balsano C
PLoS One; 2014; 9(3):e92343. PubMed ID: 24658135
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
Sarhan MA; Chen AY; Michalak TI
PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis.
Blackard JT; Kong L; Huber AK; Tomer Y
Thyroid; 2013 Jul; 23(7):863-70. PubMed ID: 23259732
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived hepatitis C virus and JFH-1 clones differ in their ability to infect human hepatoma cells and lymphocytes.
Sarhan MA; Chen AY; Russell RS; Michalak TI
J Gen Virol; 2012 Nov; 93(Pt 11):2399-2407. PubMed ID: 22855787
[TBL] [Abstract][Full Text] [Related]
17. Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.
Laidlaw SM; Marukian S; Gilmore RH; Cashman SB; Nechyporuk-Zloy V; Rice CM; Dustin LB
Gastroenterology; 2017 Aug; 153(2):566-578.e5. PubMed ID: 28456632
[TBL] [Abstract][Full Text] [Related]
18. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
Douam F; Bobay LM; Maurin G; Fresquet J; Calland N; Maisse C; Durand T; Cosset FL; Féray C; Lavillette D
J Virol; 2016 Jan; 90(2):992-1008. PubMed ID: 26537674
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
